Location via proxy:   [ UP ]  
[Report a bug]   [Manage cookies]                
Product logins

Find logins to all Clarivate products below.


Combining Clarivate’s robust proprietary data with extensive bespoke consulting advisory and custom research and analytics capabilities, we develop nuanced, defendable assessments and strategies to help biopharmaceutical and medtech clients make better, more informed decisions in a rapidly changing landscape.

By harnessing deep domain knowledge, proprietary data sets, and broad methodological capabilities, we provide innovative problem-solving approaches to biopharma and medtech’s toughest challenges. Our pioneering insight-enabled consulting model sets us apart, empowering us to focus on co-creation, thought partnership, and custom solutions.

 

We help our clients across four major pillars of the product lifecycle.

New product and portfolio strategy

Developing an approach that maximizes product and portfolio impact requires a detailed, nuanced understanding of disease area and industry dynamics. We empower our clients to seize market opportunities and craft winning product and portfolio strategies.

Backed by deep domain knowledge and extensive experience from proof of concept through lifecycle management, our team delivers strategic, data-driven recommendations to support clinical development, enable effective product positioning, and fuel successful market adoption.​

Offerings include:

  • Therapy Area Strategy
  • New Market Entry Strategy
  • Growth and Value Maximization Strategy
  • Portfolio Optimization and Prioritization
  • Market, TA, Indication and Asset Opportunity Assessments
  • TPP Development and Testing
  • Demand Studies / Forecasting
  • Positioning / Competitive Differentiation Strategy
  • Integrated Patient Journey
  • Site of Care Analysis
  • BD&L Target Search
  • Commercial Due Diligence

Clinical, economic and real-world evidence

We provide technical consulting and expertise across the product journey, helping our clients maximize the value of their available evidence and addressing gaps to support successful access and reimbursement strategies within their target markets.

Our team consists of technical experts including health economists, statisticians, medical writers, in-house graphic designers, commercial assessment analysts, systematic reviewers, and COA specialists, enabling us to provide bespoke, end-to-end solutions across the product lifecycle with the goal of optimizing market access.

Offerings include:

  • Custom Epidemiology Studies
  • RWE Study Design and Execution (Epi Studies, Registry Analysis, HCRU Analysis, Retrospective Chart Reviews, Prospective Studies)
  • Early Analysis and Economic Modelling
  • Clinical Outcomes Assessments (PROs and Patient Preference Studies)
  • Core Global Economic Modelling (CEMs & BIMs)
  • Systematic Literature Reviews and Network Meta-Analysis

Pricing and market access

Critical to the commercial success of a product is a detailed understanding of its market access potential. Our team’s extensive experience and proprietary data assets enable us to guide our clients through the evolving complexities of global reimbursement markets with thoughtful consideration of the unique dynamics at play.  We empower our clients to understand regulatory and payer trends, evidence requirements, and innovative strategies for optimizing pricing and market access.

Offerings include:

  • Access Landscapes and Account Journey Pathways
  • Indication Prioritization
  • TPP Development and Testing
  • Gap Analysis and Evidence Generation Strategy
  • Launch Pricing
  • Payer / Account Archetyping, Segmentation and Engagement Planning
  • Contracting and Formulary
  • Placement Strategy and Simulation
  • Mock Negotiation Workshops
  • HTA Submissions and Support

Customer engagement strategy and value communication

Designing and deploying an effective, well-orchestrated omnichannel customer engagement model is critical to a brand’s success during every phase of the product life cycle. Our team supports clients through every step of the process, from strategy to execution, leveraging a broad range of technology-enabled tools. Complementary to the customer engagement model is value communication. Developing and communicating a robust value proposition that resonates with physicians, payers and patients is paramount to brand success.  Our experts design value-focused, evidence-based messaging to engage customers effectively utilizing a wide range of assets and channels to communicate product value and support pricing discussions.

Offerings include:

  • Brand Launch Strategy and Tactical Support
  • Go-to-Market Model Design and Deployment
  • Customer Profiling, Segmentation and Targeting
  • Customer and Influence Network Mapping
  • Buying Process Mapping
  • Digital / Omnichannel Engagement
  • Point of Care dMessaging
  • Value Proposition / Story Development and Testing
  • Global Value Dossiers (and iGVDs) and Objection Handlers
  • Value Tool Roll-Out and Training
  • Publication and Conference Support

599k+
competitive Intelligence database that covers 599k+ drugs and biologics
300m+
300m+ patient and 2100 provider records in our real-world databases
40
custom research and consulting capabilities in 40 countries

Check out our latest webinars

Pinpoint your ideal patient and address true patients’ needs through discovering and designing treatments with comprehensive scientific and clinical intelligence.

Let's get real about data and AI
Webinar
Let's get real about data and AI
Old drugs, new life: Harnessing drug repurposing for breakthrough treatments
Webinar
Old drugs, new life: Harnessing drug repurposing for breakthrough treatments
Using Real-World Data to better understand rare diseases
Webinar
Using Real-World Data to better understand rare diseases

Our latest thought leadership

Customer Case Study – SPRIND Customer Case Study – SPRIND
Case study
Customer Case Study – SPRIND
German federal agency SPRIND turned to Clarivate for assistance in evaluating potential investments in breakthrough innovations, particularly in the field of biotech.
What to watch in the life sciences in 2024 What to watch in the life sciences in 2024
Blog December 14, 2023
What to watch in the life sciences in 2024

It’s the season of predictions and projections. Here are a few trends in life sciences and healthcare our analysts are keeping an eye on – and what they expect to…

U.S. market access landscape: A push for control is erasing the boundary between payers and providers in U.S. healthcare U.S. market access landscape: A push for control is erasing the boundary between payers and providers in U.S. healthcare
Blog April 24, 2023
U.S. market access landscape: A push for control is erasing the boundary between payers and providers in U.S. healthcare

Major U.S. healthcare payers and providers are consolidating at a dizzying clip as they seek to gain market share, increase access to care and secure clinical control to improve health…

Companies to Watch 2023 Companies to Watch 2023
Companies to Watch 2023

Seven promising early-stage companies working on AI and ML applications for drug discovery and development

Rebates are likely driving U.S. payer coverage of GLP-1 agonists Rebates are likely driving U.S. payer coverage of GLP-1 agonists
Blog March 19, 2024
Rebates are likely driving U.S. payer coverage of GLP-1 agonists

Payers’ reaction to the newly approved obesity drugs suggest manufacturers are offering significant rebates to reduce the use of restrictions and even facilitate preferred access. Long available for type 2…

Drugs to Wtach Drugs to Wtach
Drugs to Wtach
[page wil need to be added when created]
Building a business through economic uncertainty: tales from the biotech trenches Building a business through economic uncertainty: tales from the biotech trenches
Blog May 8, 2023
Building a business through economic uncertainty: tales from the biotech trenches

Timing is everything. That was the overarching sentiment from the experienced group of  biopharma leaders that formed the panel discussion chaired by Mike Ward, Clarivate Global Head of Life Sciences…

chevron_left
chevron_right

Let's talk

Learn how Clarivate consultants can provide the insight and foresight across your drug and device lifecycle.